FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
In weight loss battle, Novo and Lilly face growing offensive from licensed copies
By Andrew Silver SHANGHAI (Reuters) -As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss ...
In weight loss battle, Novo and Lilly face growing offensive from licenced copies
As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...